{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:54:17Z","timestamp":1785772457316,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"DOI":"10.1007\/s00105-026-05757-4","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:46Z","timestamp":1785769366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gemcitabin-induzierte toxisch epidermale Nekrolyse bei Mycosis fungoides","Gemcitabine-induced toxic epidermal necrolysis in a\u00a0patient with mycosis fungoides"],"prefix":"10.1007","author":[{"given":"Ana-Lee","family":"Gerdes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Vidakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Craus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Laura","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"5757_CR1","volume":"2012","author":"S D\u2019epiro","year":"2012","unstructured":"D\u2019epiro\u00a0S, Salvi\u00a0M, Mattozzi\u00a0C et\u00a0al (2012) Gemcitabine-induced extensive skin necrosis. Case Rep Med 2012:831616","journal-title":"Case Rep Med"},{"issue":"4","key":"5757_CR2","first-page":"537","volume":"20","author":"E Dippel","year":"2022","unstructured":"Dippel\u00a0E, Assaf\u00a0C, Becker\u00a0JC et\u00a0al (2022) S2k-Leitlinie - Kutane Lymphome (ICD 10 C82-C86): Update 2021. J\u00a0Dtsch Dermatol Ges 20(4):537\u2013555","journal-title":"J Dtsch Dermatol Ges"},{"key":"5757_CR3","doi-asserted-by":"crossref","unstructured":"Heuer R, Paulmann M et\u00a0al. (2024) S3-Leitlinie Diagnostik und Therapie der epidermalen Nekrolyse (Stevens-Johnson-Syndrom und toxisch epidermale Nekrolyse) \u2013 Teil\u00a01: Diagnostik, initiales Management und immunmodulierende Systemtherapie J Dtsch Dermatol Ges (in print)","DOI":"10.1111\/ddg.15515_g"},{"issue":"3","key":"5757_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2133.2009.09230.x","volume":"161","author":"K Jidar","year":"2009","unstructured":"Jidar\u00a0K, Ingen-Housz-Oro\u00a0S, Beylot-Barry\u00a0M et\u00a0al (2009) Gemcitabine treatment in cutaneous T\u2011cell lymphoma: a multicentre study of 23 cases. Br J Dermatol 161(3):660\u2013663","journal-title":"Br J Dermatol"},{"issue":"4","key":"5757_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jaad.2004.10.877","volume":"52","author":"A Kreuter","year":"2005","unstructured":"Kreuter\u00a0A, Hoffmamm\u00a0K, Altmeyer\u00a0P (2005) A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T\u2011cell lymphoma, responding to extracorporeal photopheresis. J\u00a0Am Acad Dermatol 52(4):706\u2013708","journal-title":"J Am Acad Dermatol"},{"key":"5757_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113343","volume":"195","author":"J Latzka","year":"2023","unstructured":"Latzka\u00a0J, Assaf\u00a0C, Bagot\u00a0M et\u00a0al (2023) EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - Update 2023. Eur J Cancer 195:113343","journal-title":"Eur J Cancer"},{"issue":"11","key":"5757_CR7","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/cncr.21449","volume":"104","author":"E Marchi","year":"2005","unstructured":"Marchi\u00a0E, Alinari\u00a0L, Tani\u00a0M et\u00a0al (2005) Gemcitabine as frontline treatment for cutaneous T\u2011cell lymphoma: phase II study of 32 patients. Cancer 104(11):2437\u20132441","journal-title":"Cancer"},{"key":"5757_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00105-025-05547-4","volume":"76","author":"S Mihalceanu","year":"2025","unstructured":"Mihalceanu\u00a0S, Toberer\u00a0F (2025) Poikilodermatische Mycosis fungoides. Dermatologie 76:730\u2013734","journal-title":"Dermatologie"},{"key":"5757_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1141108","volume":"13","author":"D Miyashiro","year":"2023","unstructured":"Miyashiro\u00a0D, Sanches\u00a0JA (2023) Mycosis fungoides and S\u00e9zary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Front Oncol 13:1141108","journal-title":"Front Oncol"},{"issue":"11","key":"5757_CR10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00277-014-2121-1","volume":"93","author":"C Pellegrini","year":"2014","unstructured":"Pellegrini\u00a0C, Stefoni\u00a0V, Casadei\u00a0B et\u00a0al (2014) Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine. Ann Hematol 93(11):1853\u20131857","journal-title":"Ann Hematol"},{"key":"5757_CR11","doi-asserted-by":"crossref","unstructured":"Zinzani PL, Venturini F, Stefoni V et\u00a0al. (2010) Gemcitabine as single agent in pretreated T\u2011cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol. (4):860\u2013863","DOI":"10.1093\/annonc\/mdp508"},{"issue":"5","key":"5757_CR12","first-page":"582","volume":"17","author":"PM Zito","year":"2018","unstructured":"Zito\u00a0PM, Gonzalez\u00a0AM, Fox\u00a0JD et\u00a0al (2018) Widespread Skin Necrosis Secondary to Gemcitabine Therapy. J\u00a0Drugs Dermatol 17(5):582\u2013585","journal-title":"J Drugs Dermatol"},{"issue":"8040","key":"5757_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41586-024-08061-0","volume":"635","author":"TM Nordmann","year":"2024","unstructured":"Nordmann\u00a0TM, Anderton\u00a0H, Hasegawa\u00a0A et\u00a0al (2024) Spatial proteomics identifies JAKi as treatment for a lethal skin disease. Nature 635(8040):1001\u20131009","journal-title":"Nature"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05757-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:48Z","timestamp":1785769368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05757-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":13,"alternative-id":["5757"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05757-4","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.-L.\u00a0Gerdes, M.\u00a0Vidakovic, J.\u00a0Hyun, D.\u00a0Craus, A.\u00a0Kreuter und V.L.\u00a0M\u00fcller geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}